Diabetic neuropathy

A. J M Boulton, Rayaz Malik

Research output: Contribution to journalReview article

120 Citations (Scopus)

Abstract

Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways. Effective treatment is currently limited, although a number of new and potentially important therapeutic interventions, including modification of the vascular supply and antioxidant status and growth factors, may prove to be of benefit in preventing damage and also promoting repair of peripheral nerves in human diabetic neuropathy.

Original languageEnglish
Pages (from-to)909-929
Number of pages21
JournalMedical Clinics of North America
Volume82
Issue number4
DOIs
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Peripheral Nerves
Blood Vessels
Dissection
Intercellular Signaling Peptides and Proteins
Antioxidants
Pathology
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diabetic neuropathy. / Boulton, A. J M; Malik, Rayaz.

In: Medical Clinics of North America, Vol. 82, No. 4, 1998, p. 909-929.

Research output: Contribution to journalReview article

Boulton, A. J M ; Malik, Rayaz. / Diabetic neuropathy. In: Medical Clinics of North America. 1998 ; Vol. 82, No. 4. pp. 909-929.
@article{da71dd2b2eeb48d8ad85a32c9d250674,
title = "Diabetic neuropathy",
abstract = "Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways. Effective treatment is currently limited, although a number of new and potentially important therapeutic interventions, including modification of the vascular supply and antioxidant status and growth factors, may prove to be of benefit in preventing damage and also promoting repair of peripheral nerves in human diabetic neuropathy.",
author = "Boulton, {A. J M} and Rayaz Malik",
year = "1998",
doi = "10.1016/S0025-7125(05)70029-8",
language = "English",
volume = "82",
pages = "909--929",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Diabetic neuropathy

AU - Boulton, A. J M

AU - Malik, Rayaz

PY - 1998

Y1 - 1998

N2 - Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways. Effective treatment is currently limited, although a number of new and potentially important therapeutic interventions, including modification of the vascular supply and antioxidant status and growth factors, may prove to be of benefit in preventing damage and also promoting repair of peripheral nerves in human diabetic neuropathy.

AB - Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways. Effective treatment is currently limited, although a number of new and potentially important therapeutic interventions, including modification of the vascular supply and antioxidant status and growth factors, may prove to be of benefit in preventing damage and also promoting repair of peripheral nerves in human diabetic neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=0031853860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031853860&partnerID=8YFLogxK

U2 - 10.1016/S0025-7125(05)70029-8

DO - 10.1016/S0025-7125(05)70029-8

M3 - Review article

C2 - 9706126

AN - SCOPUS:0031853860

VL - 82

SP - 909

EP - 929

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 4

ER -